DIREXION SHARES ETF TRUST

ANNUAL REPORT OCTOBER 31, 2022

1301 Avenue of the Americas (6th Ave.), 28th Floor  New York, New York 10019  www.direxioninvestments.com

Direxion Auspice Broad Commodity Strategy ETF (Consolidated)

Direxion Breakfast Commodities Strategy ETF (Consolidated)

Direxion Hydrogen ETF

Direxion Moonshot Innovators ETF

Direxion mRNA ETF

Direxion Nanotechnology ETF

Direxion NASDAQ-100® Equal Weighted Index Shares

Direxion Work From Home ETF

You can find a Fund's prospectus, reports to shareholders, and other information about the Fund online at http://www.direxioninvestments.com/regulatory-documents. You can also get this information at no cost by calling (800) 851-0511 or by sending an email request to info@direxionfunds.com.


Table of Contents

Letter to Shareholders (Unaudited)    

4

   
Performance Summary (Unaudited)    

10

   
Expense Example (Unaudited)    

18

   
Allocation of Portfolio Holdings (Unaudited)    

20

   
Schedules of Investments    

21

   
Statements of Assets and Liabilities    

30

   
Statements of Operations    

32

   
Statements of Changes in Net Assets    

34

   
Financial Highlights    

38

   
Notes to the Financial Statements    

39

   
Report of Independent Registered Public
Accounting Firm
   

51

   
Supplemental Information (Unaudited)    

53

   
Board Review of Investment Advisory
Agreement (Unaudited)
   

54

   
Board Review of Liquidity Risk
Management Program (Unaudited)
   

59

   
Trustees and Officers (Unaudited)    

60

   

Help Preserve the Environment – Go Green!

Go paperless with Direxion e-Delivery – a service allowing shareholders to reduce clutter with full online access to regulatory documents. Begin the preservation process with e-delivery.

With Direxion e-Delivery, you can:

•  Receive email notifications when your most recent shareholder communications are available for review.

•  Access prospectuses, annual reports and semi-annual reports online.

It's easy to enroll:

1.  Visit www.direxioninvestments.com/edelivery

2.  Follow the simple enrollment instructions

If you have questions about Direxion e-Delivery services, contact one of our shareholder representatives at 800-851-0511.


Letter to Shareholders (Unaudited)

Dear Shareholders,

This Annual Report for the Direxion Shares exchange traded funds (the "ETFs") covers the period from November 1, 2021 to October 31, 2022 (the "Annual Period").

Market Review:

Signs of broad-based inflation began in the fall of 2021, leading to a shaky global equity market environment. At the time, most experts predicted inflation levels were transitory, quelling investor concerns temporarily. Equity markets began to pick up through December, ending the year on a high. However, it soon became clear the widespread inflation was not going anywhere and the Federal Reserve announced an acceleration of monetary policy that was implemented through a series of interest rate hikes to combat inflation. Simultaneously, the highly contagious Covid-19 Omicron variant spread across the world and, despite high vaccination rates, breakthrough infections were at an all-time high. However, by the end of the Annual Period, Covid was far less of a concern for investors. Just as markets were looking up again, with the S&P 500 posting its first monthly gain in March 2022, Russia invaded Ukraine, and the effects of the invasion rippled across equity markets, as energy prices surged and fears of wider-spread conflict grew. In response, the United States and other western nations imposed extreme economic sanctions on Russia. Markets were very volatile on the heels of the Russian invasion, and the first two quarters of 2022 saw a shrinking U.S. GDP. June earnings reports were surprisingly strong, despite a mid-month S&P low. Despite these numbers, July was a strong month, but this positive sentiment did not last long. A hawkish speech from Federal Reserve Chair, Jerome Powell, in August negatively impacted markets around the world. September was another rough month for equities, with both the S&P 500 and NASDAQ dropping roughly 10%. Global markets fared no better, as the UK entered a recession, and China faced mass protests and unrest. October saw a modest increase in stocks as the Federal Reserve indicated it will pull back on its aggressive tightening in the near future after positive third quarter readings, but overall sentiment was still generally low. Investors are pivoting towards more risk-off investments in an attempt to navigate historic inflation levels, geopolitical conflict and high interest rates, although traditional safe haven investments, such as commodities, are less appealing than they have been in the past.

The U.S. bond market was in consistent decline for the majority of the Annual Period, oftentimes diverging from trends in the equities markets. In the fall, treasuries and international bonds were experiencing the worst performance of the Annual Period, as concerns over rising interest rates and inflation began. As inflation worsened and proved to be less transitory than initially predicted, central banks around the world pivoted towards more hawkish policies. In December, the Federal Reserve announced there would be three or four rate hikes throughout 2022, as well as a tapering of U.S. treasury asset purchases. In late February, the Russian invasion of Ukraine rippled through the global financial system, including fixed income markets. The U.S. Treasury yield curve started to flatten as the 10 – 20 year bond spread grew and became inverted. While bonds have typically been considered a way to hedge a portfolio against equities, this strategy has not typically held true in the current market environment. After the positive indication that the Federal Reserve is starting to get a handle on inflation, the global bond market saw a slight rebound, but the yield curve remained inverted at the end of the Annual Period, which remains a concern for many investors.

Factors Affecting the ETFs Performance:

Benchmark Performance – The performance of each ETF's benchmark index, and the factors and market conditions implicitly affecting that index, are the primary factors driving ETF performance. The market conditions that affected the benchmark indexes during the past year are described in the Market Review section above.

Fees, Expenses, and Transaction Costs – Fees and expenses are listed in each ETF's prospectus and may be higher than many traditional index funds' fees, which cause a greater negative impact on ETF performance. Transaction costs are not included in the expense ratio of the ETFs.

DIREXION ANNUAL REPORT
4


The ETFs Performance Review:

The following discussion relates to the performance of the ETFs for the Annual Period. The performance of the ETFs for the Annual Period is important primarily for understanding whether the ETFs meet their investment goals. All ETF returns are NAV (net asset value) returns.

Non-Leveraged ETFs

The Direxion Auspice Broad Commodity Strategy ETF seeks investment results, before fees and expenses, that track the Auspice Broad Commodity Index over a complete market cycle. The Auspice Broad Commodity Index seeks to capture the majority of the commodity upside returns, while seeking to mitigate downside risk. The Auspice Broad Commodity Index will use a quantitative methodology to track either long or flat positions in a diversified portfolio of 12 different commodity futures contracts, or "components", which cover the energy, metal, and agricultural sectors. It attempts to incorporate dynamic risk management and contract rolling methods. For the Annual Period, the Auspice Broad Commodity Index returned 6.21%, while the Direxion Auspice Broad Commodity Strategy ETF returned 6.09%.

Until the last few months of the Annual Period, commodities had rallied in an otherwise bear market, primarily due to inflation. In particular, the energy and agriculture holdings of the Direxion Auspice Broad Commodity Strategy ETF performed well. Heating oil futures were up 58.69% and natural gas futures were up 55.64% over the Annual Period. The performance for metals was less positive, with silver down 20.59%, gold down 8.47%, and copper down 21.33%. The Direxion Auspice Broad Commodity Strategy ETF had relatively strong performance despite overall market volatility, largely due to the favorable commodity environment in the beginning-to-middle of 2022.

The Direxion Breakfast Commodities Strategy ETF seeks investment results, before fees and expenses, that track the S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index. The S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index measures the performance of tradeable commodities considered to be breakfast foods (corn, coffee, lean hogs, sugar, Chicago wheat and orange juice) by investing in monthly futures contracts for such commodities. The Index is world production weighted and designed to reflect the relative significance of each of the commodities to the world economy, except for orange juice which is capped at 5%. The Index is rebalanced annually and employs a flexible monthly futures rolling strategy. Since the Fund's inception on June 1, 2022, the S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index returned -9.04%, while the Direxion Breakfast Commodities Strategy ETF returned -8.19%.

The Direxion Breakfast Commodities Strategy ETF opened during the commodity rally. Soon after, the commodity market began to fall as many headwinds hit the space, including the Russia-Ukraine conflict, widespread droughts and labor shortages, just to name a few. Lean Hogs, Corn, Orange Juice and Sugar have had positive returns since the fund's inception, while Coffee and Wheat have fallen.

The Direxion Hydrogen ETF seeks investment results, before fees and expenses, that track the Indxx Hydrogen Economy Index. The Indxx Hydrogen Economy Index tracks the performance of companies that provide goods and/or services related to the Hydrogen Industry, including hydrogen generation and storage, fuel cells, hydrogen stations, and hydrogen-based vehicles. The Index includes domestic securities as well as securities listed on various foreign markets, including among others, Japan and South Korea. The Index is reconstituted annually and rebalanced quarterly. For the Annual Period, the Indxx Hydrogen Economy Index returned -45.79%, while the Direxion Hydrogen ETF returned -45.57%.

Kaori Heat Treatment was the top performer, while ITM Power Plc brought up the rear for the Direxion Hydrogen ETF. Two of the biggest names in the hydrogen industry, Plug Power (PLUG) and Bloom Energy (BE), experienced significant losses during the Annual Period. However, hydrogen is gaining momentum as an important source for the global energy transition, especially after the passage of the Inflation Reduction Act, which includes provisions for hydrogen tax credits.

The Direxion Moonshot Innovators ETF seeks investment results, before fees and expenses, that track the S&P Kensho Moonshots Index. The S&P Kensho Moonshots Index is comprised of 50 U.S. companies that pursue innovative technologies that have the potential to disrupt existing technologies and/or industries (i.e., moonshot innovators) and are considered to

DIREXION ANNUAL REPORT
5


have the highest "early-stage composite innovation scores" which is determined based off a natural language processing review of the constituent company's latest annual regulatory filing for the use of words and phrases that are related to innovation. The Index is modified equal-weighted, reconstituted annually, and rebalanced semi-annually. For the Annual Period, the S&P Kensho Moonshots Index returned -60.92%, while the Direxion Moonshot Innovators ETF returned -60.64%.

Some more well-known names, such as Yelp and Roblox, experienced losses during the Annual Period. Adeia Inc. and Innoviz Technologies were the top performers for the Direxion Moonshot Innovators ETF this Annual Period. Overall, tech names have had difficulties recently, and IT companies make up roughly 50% of the portfolio.

The Direxion mRNA ETF seeks investment results, before fees and expenses, that track the BITA Messenger RNA Technology Index. The BITA Messenger RNA Technology Index provides exposure to the performance of companies, publicly listed in the United States, Canada and Europe, that are leading the development and application of messenger RNA ("mRNA") technology. mRNA is a single-stranded ribonucleic acid ("RNA") molecule that is complementary to one of the DNA strands of a gene. mRNA plays a vital role in protein synthesis in the human body, and mRNA technologies leverage this vital role to enable targeted cells to produce proteins that enable the body to fight or prevent a given disease. As an example, mRNA technology is the basis for certain COVID-19 vaccines. Eligible companies must meet certain conditions as specified by the Index Provider as well as market capitalization and liquidity requirements. Index constituents are weighted based on a modified free float market capitalization and reconstituted and rebalanced quarterly. Since the Fund's inception on December 9, 2021, the BITA Messenger RNA Technology Index returned -43.11%, while the Direxion mRNA ETF returned -43.20%.

The top performer for the Direxion mRNA ETF during the Annual Period was Vertex Pharmaceuticals (VRTX), which returned 68.28% and has a portfolio weight of 7.37%, which is one of the highest weighted stocks in the Direxion mRNA ETF. Well-known bio tech companies Moderna (MRNA) and Bio N Tech (BNTX) experienced similar losses of -55.4% and -49.1%, respectively. Curevac (CVAC) was the worst performer, losing -82.71% this Annual Period, with a weight of 4.01%.

The Direxion Nanotechnology ETF seeks investment results, before fees and expenses, that track the S&P Kensho Extended Nanotechnology Index. The S&P Kensho Extended Nanotechnology Index, a subsector index within the S&P Kensho New Economy Index Series, is designed to measure the performance of U.S. listed securities, including depositary receipts, of companies involved in the nanotechnology industry. The Index Provider defines nanotechnology as the creation and/or manipulation of matter at the molecular (or smaller) level. The Index includes companies that produce nanomaterials or provide systems, products and services that allow for construction, measurement, simulation or manipulation of nanomaterials. Since the Fund's inception on November 23, 2021, the S&P Kensho Extended Nanotechnology Index returned -35.25%, while the Direxion Nanotechnology ETF returned -35.44%.

Liquidia Corp (LQDA), Cabot Corp (CBT), and Alnylam Pharmaceuticals (ALNY) were the top performers for the Direxion Nanotechnology ETF this Annual period. However, many other names in the healthcare sector, which makes up nearly 70% of the Direxion Nanotechnology ETF, did not fare as well. Well-known Moderna (MRNA) returned -55.41% and Bio N Tech (BNTX) returned -49.15% during the period, each with a portfolio weight of roughly 3%. Bruker Corp. (BRKR) is the top holding, making up 11.47% of the portfolio, and lost -23.64% this period.

The Direxion NASDAQ-100® Equal Weighted Index Shares seeks investment results, before fees and expenses, that track the NASDAQ-100® Equal Weighted Index. The NASDAQ-100® Equal Weighted Index is the equal weighted version of the NASDAQ-100 Index® which includes approximately 100 of the largest domestic and international non-financial companies listed on the NASDAQ® Stock Market based on market capitalization selected by NASDAQ, Inc., the index provider. Equal weighting is a method of weighting index stocks whereby the same exposure is provided to both the smallest and largest companies included in the Index. The Index is rebalanced quarterly and reconstituted annually. For the Annual Period, the NASDAQ-100® Equal Weighted Index returned -23.58%, while the Direxion NASDAQ-100® Equal Weighted Index Shares returned -23.78%.

The top performers for the Direxion NASDAQ-100® Equal Weighted Index Shares during this period were largely biotech name,s including Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) returning 33.15% and 68.28%, respectively. The IT sector had a rough year, with names like Netflix, Docusign, and Meta losing -60% to -70% each.

DIREXION ANNUAL REPORT
6


The Direxion Work From Home ETF seeks investment results, before fees and expenses, that track the Solactive Remote Work Index. The Solactive Remote Work Index is comprised of U.S. listed securities and ADRs of companies that provide products and services in at least one of the following business segments that facilitate the ability of people to work from home: remote communications, cyber security, online project and document management, and cloud computing technologies ("WFH Industries"). The Index consists of 40 companies, namely, the top 10 ranked companies in each of the four WFH Industries. The Index is equal weighted at each semi-annual reconstitution and rebalance date. For the Annual Period, the Solactive Remote Work Index returned -42.95%, while the Direxion Work From Home ETF returned -43.00%.

IBM was the top performer for the Direxion Work From Home ETF during the Annual Period, returning 20.60%. Names such as Agora and RingCentral were among bottom performers, falling -88.27% and -85.93%, respectively. Names in the IT sector make up 86.99% of the Direxion Work From Home ETF, and tech generally had a rough year.

Index Volatility:

The Annual Period was extremely volatile, leaving investors without a clear strategy, and no clear sector winner. Typically defensive stocks were not immune to the volatility, and the market cycles were moving unpredictably. The VIX Index, a measure of volatility and market sentiment, averaged 25.20 during the Annual Period, with a high of 36.45 in early March 2022, whereas the average for the previous five years was 20.94.

Index

 

Return

 

Volatility

 

Auspice Broad Commodity Index

   

6.09

%

   

12.14

%

 

S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index1

   

-9.04

%

   

20.23

%

 

Indxx Hydrogen Economy Index

   

-45.79

%

   

34.81

%

 

S&P Kensho Moonshots Index

   

-60.92

%

   

55.61

%

 

BITA Messenger RNA Technology Index2

   

-43.11

%

   

47.45

%

 

S&P Kensho Extended Nanotechnology Index3

   

-35.25

%

   

47.33

%

 

NASDAQ-100® Equal Weighted Index

   

-23.58

%

   

29.06

%

 

Solactive Remote Work Index

   

-42.95

%

   

36.66

%

 

1  June 1, 2022 through October 31, 2022

2  December 9, 2021 through October 31, 2022

3  November 23, 2021 through October 31, 2022

As always, we thank you for using the Direxion Shares ETFs and we look forward to our mutual success.

Best Regards,

 

 

Patrick Rudnick

 

Corey Noltner

 

Principal Executive Officer

 

Principal Financial Officer

 

An investor should carefully consider a Fund's investment objective, risks, charges, and expenses before investing. A Fund's prospectus and summary prospectus contain this and other information about the Direxion Shares. To obtain a Fund's prospectus and summary prospectus call 866-476-7523 or visit our website at direxion.com. A Fund's prospectus and summary prospectus should be read carefully before investing.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate. An investor's shares, when redeemed,

DIREXION ANNUAL REPORT
7


may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted. Returns for performance under one year are cumulative, not annualized. For the most recent month-end performance please visit the Fund's website at direxion.com.

Short-term performance, in particular, is not a good indication of the Fund's future performance, and an investment should not be made based solely on returns. Because of ongoing market volatility, Fund performance may be subject to substantial short-term changes. For additional information, see the Fund's prospectus.

Shares of the Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from a Fund. Market Price returns are based upon the midpoint of the bid/ask spread at 4:00 pm EST (when NAV is normally calculated) and do not represent the returns you would receive if you traded shares at other times. Brokerage commissions will reduce returns. Fund returns assume that dividends and capital gains distributions have been reinvested in the Fund at NAV.

SOFR (Secured Overnight Financing Rate) is a broad measure of the cost of borrowing cash overnight collateralized by Treasury securities. Futures Contract: an agreement traded on an organized exchange to buy or sell assets, especially commodities or shares, at a fixed price but to be delivered and paid for later.

Direxion Auspice Broad Commodity Strategy ETF and Direxion Breakfast Commodities Strategy ETF – Commodities and futures generally are volatile and are not suitable for all investors. The value of a commodity-linked derivative investment typically is based upon the price movements of a physical commodity and may be affected by changes in overall market movements, volatility of the underlying index, changes in interest rates, or factors affecting a particular industry or commodity, such as drought, floods, weather, embargoes, tariffs and international economic, political and regulatory developments. Commodity linked derivatives also may be subject to credit and interest rate risks that in general affect the values of debt securities. A Fund's investments in derivatives may pose risks in addition to, and greater than, those associated with directly investing in securities or other investments, including risk related to leverage, imperfect correlations with underlying investments or a Fund's other portfolio holdings, higher price volatility, lack of availability, counterparty risk, liquidity, valuation and legal restrictions. The use of derivatives is a highly specialized activity that involves investment techniques and risks different from those associated with ordinary portfolio securities transactions. Futures contracts are typically exchange traded contracts that call for the future delivery of an asset at a certain price and date, or cash settlement of the terms of the contract. Futures markets are highly volatile and the use of futures may increase the volatility of a Fund. There may be an imperfect correlation between the changes in market value of the securities held by a Fund and the prices of futures contracts. There may not be a liquid secondary market for the futures contracts.

Under amended regulations promulgated by the U.S. Commodities Futures Trading Commission ("CFTC"), a Fund and its Subsidiary are considered commodity pools, and therefore each is subject to regulation under the Commodity Exchange Act and CFTC rules. The Adviser is registered as a commodity pool operator ("CPO") and will manage the Funds and Subsidiaries in accordance with CFTC rules, as well as the rules that apply to registered investment companies, which includes registering both each Fund and its Subsidiary as commodity pools. Registration as a commodity pool subjects the registrant to additional laws, regulations and enforcement policies, all of which may potentially increase compliance costs and may affect the operations and financial performance of each Fund or its Subsidiary. Additionally, a Subsidiary's positions in futures contracts may have to be liquidated at disadvantageous times or prices to prevent a Fund from exceeding any applicable position limits established by the CFTC. Such actions may subject the Fund to substantial losses.

Direxion Shares ETF Risks – An investment in the ETFs involves risk, including the possible loss of principal. The ETFs are subject to certain risks, including imperfect index correlation and market price variance, that may decrease performance. As non-diversified funds, the ETFs may invest in a relatively small number of issuers and, as a result, be subject to greater risk of loss with respect to its portfolio securities. An ETF may concentrate its investments in certain industries or sectors, which can increase volatility. The ETFs may experience greater fluctuation in its net asset value as compared to other investments. These ETFs may be appropriate for investors

DIREXION ANNUAL REPORT
8


with a long-term investment time horizon, who primarily seek capital growth, and who are able to tolerate periods of prolonged price declines. Please read each ETF's prospectus for a more complete description of the investment risks. There is no guarantee that an ETF will achieve its investment objective. The views of this letter were those of the Adviser as of October 31, 2022 and may not necessarily reflect its views on the date this letter is first published or anytime thereafter. These views are intended to help shareholders in understanding the ETFs' present investment methodology and do not constitute investment advice.

Distributed by: Foreside Fund Services, LLC

DIREXION ANNUAL REPORT
9


Direxion Auspice Broad Commodity Strategy ETF (Consolidated)

Performance Summary (Unaudited)

March 30, 20171 - October 31, 2022

   

Average Annual Total Return2

 
   

1 Year

 

3 Year

 

5 Year

 

Since Inception

 
Direxion Auspice Broad Commodity Strategy ETF (Consolidated)
(NAV)
   

6.21

%

   

14.01

%

   

8.63

%

   

6.75

%

 
Direxion Auspice Broad Commodity Strategy ETF (Consolidated)
(Market Price)
   

5.86

%

   

13.97

%

   

8.57

%

   

6.72

%

 

Auspice Broad Commodity Index

   

6.09

%

   

14.09

%

   

7.81

%

   

5.78

%

 

The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.70%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than the following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.

This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.

The Auspice Broad Commodity Index is a tactical long strategy that focuses on Momentum and Term Structure to track either long or flat positions in a diversified portfolio of commodity futures which cover the energy, metal, and agricultural sectors. The index incorporates dynamic risk management and contract rolling methods. The index is available in total return (collateralized) and excess return (non-collateralized) versions. Investors cannot invest directly in an index, although they can invest in its underlying securities.

Market Exposure

The Fund seeks daily exposure of 100% of its NAV through derivatives. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.

1  Commencement of operations.

2  As of October 31, 2022.

DIREXION ANNUAL REPORT
10


Direxion Breakfast Commodities Strategy ETF (Consolidated)

Performance Summary (Unaudited)

June 1, 20221 - October 31, 2022

 

Total Return2

 

 

Since Inception

 

Direxion Breakfast Commodities Strategy ETF (Consolidated) (NAV)

   

-8.19

%

 

Direxion Breakfast Commodities Strategy ETF (Consolidated) (Market Price)

   

-8.23

%

 

S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index

   

-9.04

%

 

The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.70%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.

This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.

The S&P GSCI Dynamic Roll Breakfast (OJ 5% Capped) Index measures the performance of tradeable commodities considered to be breakfast foods (corn, coffee, lean hogs, sugar, Chicago wheat and orange juice) by investing in monthly futures contracts for such commodities. The Index is world production weighted and designed to reflect the relative significance of each of the commodities to the world economy, except for orange juice is capped at 5%. Investors cannot invest directly in an index, although they can invest in its underlying securities.

Market Exposure

The Fund seeks daily exposure of 100% of its NAV through derivatives. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.

1  Commencement of operations.

2  As of October 31, 2022.

DIREXION ANNUAL REPORT
11


Direxion Hydrogen ETF

Performance Summary (Unaudited)

March 25, 20211 - October 31, 2022

   

Average Annual Total Return2

 
   

1 Year

 

Since Inception

 

Direxion Hydrogen ETF (NAV)

   

-45.57

%

   

-32.69

%

 

Direxion Hydrogen ETF (Market Price)

   

-45.84

%

   

-32.64

%

 

Indxx Hydrogen Economy Index

   

-45.79

%

   

-30.48

%

 

The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.45%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.

This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.

The Indxx Hydrogen Economy Index tracks the performance of companies that provide goods and/or services related to the Hydrogen Industry, including hydrogen generation and storage, fuel cells, hydrogen stations, and hydrogen-based vehicles. The Index will include domestic securities as well as securities listed on various foreign markets, including among others, Japan and South Korea. The Index is reconstituted annually and rebalanced quarterly. Investors cannot invest directly in an index, although they can invest in its underlying securities.

Market Exposure

The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.

1  Commencement of operations.

2  As of October 31, 2022.

DIREXION ANNUAL REPORT
12


Direxion Moonshot Innovators ETF

Performance Summary (Unaudited)

November 12, 20201 - October 31, 2022

   

Average Annual Total Return2

 
   

1 Year

 

Since Inception

 

Direxion Moonshot Innovators ETF (NAV)

   

-60.64

%

   

-27.31

%

 

Direxion Moonshot Innovators ETF (Market Price)

   

-60.61

%

   

-27.31

%

 

S&P Kensho Moonshots Index

   

-60.92

%

   

-27.79

%

 

The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.65%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.

This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.

The S&P Kensho Moonshots Index is comprised of 50 U.S. companies that pursue innovative technologies that have the potential to disrupt existing technologies and/or industries (i.e., moonshot innovators) and are considered to have the highest "early-stage composite innovation scores" which is determined based off a natural language processing review of the constituent company's latest annual regulatory filing for the use of words and phrases that are related to innovation. The Index is modified equal-weighted, reconstituted annually, and rebalanced semi-annually. Investors cannot invest directly in an index, although they can invest in its underlying securities.

Market Exposure

The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.

1   Commencement of operations.

2  As of October 31, 2022.

DIREXION ANNUAL REPORT
13


Direxion mRNA ETF

Performance Summary (Unaudited)

December 9, 20211 - October 31, 2022

   

Total Return2

 
   

Since Inception

 

Direxion mRNA ETF (NAV)

   

-43.20

%

 

Direxion mRNA ETF (Market Price)

   

-43.17

%

 

BITA Messenger RNA Technology Index

   

-43.11

%

 

The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.65%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.

This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.

BITA Messenger RNA Technology Index provides exposure to the performance of companies, publicly listed in the United States, Canada and Europe, that are leading the development and application of messenger RNA ("mRNA") technology. Investors cannot invest directly in an index, although they can invest in its underlying securities.

Market Exposure

The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.

1  Commencement of operations.

2  As of October 31, 2022.

DIREXION ANNUAL REPORT
14


Direxion Nanotechnology ETF

Performance Summary (Unaudited)

November 23, 20211 - October 31, 2022

   

Total Return2

 
   

Since Inception

 

Direxion Nanotechnology ETF (NAV)

   

-35.44

%

 

Direxion Nanotechnology ETF (Market Price)

   

-35.45

%

 

S&P Kensho Extended Nanotechnology Index

   

-35.25

%

 

The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.65%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.

This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.

S&P Kensho Extended Nanotechnology Index is provided by S&P Dow Jones Indices LLC (the "Index Provider") and is designed to measure the performance of U.S.-listed securities, including depositary receipts, of companies involved in the nanotechnology industry. Investors cannot invest directly in an index, although they can invest in its underlying securities.

Market Exposure

The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.

1  Commencement of operations.

2  As of October 31, 2022.

DIREXION ANNUAL REPORT
15


Direxion NASDAQ-100® Equal Weighted Index Shares

Performance Summary (Unaudited)

October 31, 2012 - October 31, 2022

   

Average Annual Total Return1

 
   

1 Year

 

3 Years

 

5 Years

 

10 Years

 

Direxion NASDAQ-100® Equal Weighted Index Shares (NAV)

   

-23.78

%

   

9.51

%

   

10.31

%

   

14.44

%

 

Direxion NASDAQ-100® Equal Weighted Index Shares (Market Price)

   

-23.68

%

   

9.53

%

   

10.33

%

   

14.44

%

 

NASDAQ-100® Equal Weighted Index

   

-23.58

%

   

9.88

%

   

10.69

%

   

14.85

%

 

The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.35%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.

This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.

The NASDAQ-100® Equal Weighted Index includes 100 of the largest non-financial securities listed on NASDAQ®, but instead of being weighted by market capitalization, each of the constituents is initially set at 1.00%. The Index is reviewed and adjusted annually in December, but replacements may be made any time throughout the year. The Index is rebalanced quarterly in March, June, September and December. Investors cannot invest directly in an index, although they can invest in its underlying securities.

Market Exposure

The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.

1  As of October 31, 2022.

DIREXION ANNUAL REPORT
16


Direxion Work From Home ETF

Performance Summary (Unaudited)

June 25, 20201 - October 31, 2022

   

Average Annual Total Return2

 
   

1 Year

 

Since Inception

 

Direxion Work From Home ETF (NAV)

   

-43.00

%

   

-4.67

%

 

Direxion Work From Home ETF (Market Price)

   

-42.98

%

   

-4.69

%

 

Solactive Remote Work Index

   

-42.95

%

   

-4.52

%

 

The performance data quoted represents past performance; past performance does not guarantee future results; the investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost; current performance may be lower or higher than the performance quoted. As stated in the current prospectus, the Fund's total annual fund operating expense ratio is 0.45%. Rafferty Asset Management, LLC has contractually agreed to pay all expenses of the Fund other than following: management fees, Rule 12b-1 distribution fees and/or service fees, taxes, swap financing and related costs, dividends or interest on short positions, other interest expenses, brokerage commissions, expenses incurred in connection with any merger or reorganization, acquired fund fees and expenses, and extraordinary expenses. The performance table and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. For the Fund's most recent month end performance please visit www.direxion.com.

This chart illustrates the performance of a hypothetical $10,000 investment made on the Fund's inception and is not intended to imply any future performance. Shares of Direxion Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Performance reflects reinvestment of all dividend and capital gains distributions.

The Solactive Remote Work Index is comprised of U.S. listed securities and American Depository Receipts of companies that provide products and services in at least one of the following business segments that facilitate the ability of people to work from home: remote communications, cyber security, online project and document management, and cloud computing technologies ("WFH Industries"). The Index consists of 40 companies, namely, the top 10 ranked companies in each of the four WFH Industries. The Index is equal weighted at each semi-annual reconstitution and rebalance date. Investors cannot invest directly in an index, although they can invest in its underlying securities.

Market Exposure

The Fund seeks daily exposure of 100% of its NAV through equities. "Market Exposure" includes the value of total investments (including the contract value of any derivatives) and excludes any short-term investments and cash equivalents, if any, divided by Net Assets.

1  Commencement of operations.

2  As of October 31, 2022.

DIREXION ANNUAL REPORT
17


Expense Example (Unaudited)

October 31, 2022

As a shareholder of the Funds, you incur two types of costs: (1) transaction costs, for purchasing and selling shares and exchange fees; and (2) ongoing costs, including management fees; and other Fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in a fund and to compare these costs with the ongoing costs of investing in other funds.

The example is based on initial investments of $1,000 invested at the beginning of the period and held the entire period (May 1, 2022 to October 31, 2022).

Actual expenses

The first line under each Fund in the table provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line for your Fund under the heading entitled "Expenses Paid During Period May 1, 2022 to October 31, 2022" to estimate the expenses you paid on your account during this period.

Hypothetical example for comparison purposes

The second line of the table below provides information about hypothetical account values and hypothetical expenses based on each Fund's actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in your Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as brokerage commissions paid on purchases and sales of Fund shares. Therefore, the second line under each Fund in the table is useful in comparing ongoing Fund costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

DIREXION ANNUAL REPORT
18


Expense Example (Unaudited)

October 31, 2022

    Annualized
Expense Ratio
  Beginning
Account Value
May 1, 2022
  Ending
Account Value
October 31, 2022
  Expenses Paid
During Period
May 1, 2022 to
October 31, 2022*
 

Direxion Auspice Broad Commodity Strategy ETF (Consolidated)

 

Based on actual fund return

   

0.86

%

 

$

1,000.00

   

$

918.50

   

$

4.16

   

Based on hypothetical 5% return

   

0.86

%

   

1,000.00

     

1,020.87

     

4.38

   

Direxion Breakfast Commodities Strategy ETF (Consolidated)1

 

Based on actual fund return

   

0.70

%

   

1,000.00

     

918.10

     

2.81

   

Based on hypothetical 5% return

   

0.70

%

   

1,000.00

     

1,018.02

     

2.96

   

Direxion Hydrogen ETF

 

Based on actual fund return

   

0.45

%

   

1,000.00

     

765.80

     

2.00

   

Based on hypothetical 5% return

   

0.45

%

   

1,000.00

     

1,022.94

     

2.29

   

Direxion Moonshot Innovators ETF

 

Based on actual fund return

   

0.65

%

   

1,000.00

     

826.40

     

2.99

   

Based on hypothetical 5% return

   

0.65

%

   

1,000.00

     

1,021.93

     

3.31

   

Direxion mRNA ETF

 

Based on actual fund return

   

0.65

%

   

1,000.00

     

986.10

     

3.25

   

Based on hypothetical 5% return

   

0.65

%

   

1,000.00

     

1,021.93

     

3.31

   

Direxion Nanotechnology ETF

 

Based on actual fund return

   

0.65

%

   

1,000.00

     

1,064.60

     

3.38

   

Based on hypothetical 5% return

   

0.65

%

   

1,000.00

     

1,021.93

     

3.31

   

Direxion NASDAQ-100® Equal Weighted Index Shares

 

Based on actual fund return

   

0.35

%

   

1,000.00

     

928.00

     

1.70

   

Based on hypothetical 5% return

   

0.35

%

   

1,000.00

     

1,023.44

     

1.79

   

Direxion Work From Home ETF

 

Based on actual fund return

   

0.45

%

   

1,000.00

     

774.50

     

2.01

   

Based on hypothetical 5% return

   

0.45

%

   

1,000.00

     

1,022.94

     

2.29

   

*  Expenses are equal to the Fund's annualized expense ratio, multiplied by the average account value over the period, multiplied by 184 days (the number of days in the period of May 1, 2022 to October 31, 2022), then divided by 365.

1  Expenses are equal to the Fund's annualized expense ratio, multiplied by the average account value over the period from June 1, 2022 (commencement of operations) to October 31, 2022, multiplied by 153 days (the number of days since commencement of operations to October 31, 2022), then divided by 365.

DIREXION ANNUAL REPORT
19


Allocation of Portfolio Holdings (Unaudited)

October 31, 2022

   

Cash*

  Common
Stocks
 

Futures

 

Total

 

Direxion Auspice Broad Commodity Strategy ETF (Consolidated)

   

100

%

   

     

     

100

%

 

Direxion Breakfast Commodities Strategy ETF (Consolidated)

   

100

%

   

     

0

%**

   

100

%

 

Direxion Hydrogen ETF

   

1

%

   

99

%

   

     

100

%

 

Direxion Moonshot Innovators ETF

   

1

%

   

99

%

   

     

100

%

 

Direxion mRNA ETF

   

0

%**

   

100

%

   

     

100

%

 

Direxion Nanotechnology ETF

   

0

%**

   

100

%

   

     

100

%

 

Direxion NASDAQ-100® Equal Weighted Index Shares

   

0

%**

   

100

%

   

     

100

%

 

Direxion Work From Home ETF

   

0

%**

   

100

%

   

     

100

%

 

*  Cash and other assets less liabilities.

**  Percentage is less than 0.5%.

DIREXION ANNUAL REPORT
20


Direxion Auspice Broad Commodity Strategy ETF (Consolidated)

Schedule of Investments

October 31, 2022

Shares

     

Fair Value

 

SHORT TERM INVESTMENTS - 101.3%

 

Money Market Funds - 101.3%

 
 

301,128,639

    Dreyfus Government Cash
Management Institutional
Shares, 2.91% (a)
 

$

301,128,639

   
    TOTAL SHORT TERM
INVESTMENTS
(Cost $301,128,639)
 

$

301,128,639

   
    TOTAL INVESTMENTS
(Cost $301,128,639) - 101.3%
 

$

301,128,639

   
    Liabilities in Excess of
Other Assets - (1.3)%
   

(3,840,833

)

 
   

TOTAL NET ASSETS - 100.0%

 

$

297,287,806

   

Percentages are stated as a percent of net assets.

The geographic location of all investments is United States unless otherwise indicated.

(a)  Represents annualized seven-day yield at October 31, 2022.

    

The accompanying notes are an integral part of these financial statements.

DIREXION ANNUAL REPORT
21


Direxion Breakfast Commodities Strategy ETF (Consolidated)

Schedule of Investments

October 31, 2022

Shares

     

Fair Value

 

SHORT TERM INVESTMENTS - 91.3%

 

Money Market Funds - 91.3%

 
 

6,273,596

    Dreyfus Government Cash
Management Institutional
Shares, 2.91% (a)
 

$

6,273,596

   
    TOTAL SHORT TERM
INVESTMENTS (Cost $6,273,596)
 

$

6,273,596

   
    TOTAL INVESTMENTS
(Cost $6,273,596) - 91.3%
 

$

6,273,596

   
    Other Assets in Excess of
Liabilities - 8.7% (b)
   

596,427

   
   

TOTAL NET ASSETS - 100.0%

 

$

6,870,023

   

Percentages are stated as a percent of net assets.

The geographic location of all investments is United States unless otherwise indicated.

(a)  Represents annualized seven-day yield at October 31, 2022.

(b)  $492,562 of cash is pledged as collateral for futures contracts.

    

Long Futures Contracts

October 31, 2022

Reference Entity

  Expiration
Date
  Number of
Contracts
  Notional
Amount
  Variation
Margin
Receivable/
(Payable), net
  Unrealized
Appreciation
(Depreciation)
 

Coffee C

 

5/18/2023

   

5

   

$

324,281

   

$

11,437

   

$

(60,675

)

 

Corn

 

12/14/2023

   

89

     

2,784,588

     

21,138

     

(18,721

)

 

Frozen Concentrate Orange Juice

 

1/10/2023

   

13

     

392,145

     

1,657

     

26,884

   

Lean Hogs

 

12/14/2022

   

24

     

815,280

     

(11,280

)

   

7,310

   

Sugar #11

 

4/28/2023

   

36

     

681,005

     

9,677

     

(69,049

)

 

Wheat

 

7/14/2023

   

40

     

1,807,500

     

84,500

     

147,600

   
           

$

6,804,799

   

$

117,129

   

$

33,349

   

All futures contracts held by Direxion BKT Fund Ltd. See Note 1.

The accompanying notes are an integral part of these financial statements.

DIREXION ANNUAL REPORT
22


Direxion Hydrogen ETF

Schedule of Investments

October 31, 2022

Shares

     

Fair Value

 

COMMON STOCKS - 99.0%

     

Chemical Manufacturing - 42.1%

     
 

14,072

   

Air Liquide S.A. (France)

 

$

1,840,032

   
 

3,921

   

Air Products & Chemicals, Inc.

   

981,819

   
 

52,997

    Doosan Fuel Cell Co., Ltd
(South Korea) (a)
   

1,013,843

   
 

520,629

   

ITM Power (United Kingdom) (a)(b)

   

495,483

   
 

3,281

   

Linde PLC (Ireland) ADR

   

975,605

   
 

27,063

   

McPhy Energy SAS (France) (a)(b)

   

307,598

   
 

1,496,312

   

Nel ASA (Norway) (a)

   

1,828,500

   
 

57,298

    Nippon Sanso Holdings Corp.
(Japan)
   

914,393

   
 

845,137

    PTT Global Chemical PCL
(Thailand)
   

965,934

   

   

9,323,207

   
Computer and Electronic Product
Manufacturing - 8.5%
     
 

100,767

   

Bloom Energy Corp. (a)

   

1,885,351

   

Electrical Equipment, Appliance, and Component Manufacturing - 12.4%

     
 

64,956

    Chung-Hsin Electric & Machinery
Manufacturing Corp. (Taiwan)
   

99,584

   
 

2,894

    Hyosung Heavy Industries
(South Korea) (a)
   

116,617

   
 

101,989

   

Plug Power, Inc. (a)

   

1,629,784

   
 

61,132

    PowerCell Sweden AB
(Sweden) (a)(b)
   

672,148

   
 

6,495

   

SFC Energy AG (Germany) (a)(b)

   

119,913

   
 

3,882

   

VARTA AG (Germany) (b)

   

104,245

   
     

2,742,291

   

Merchant Wholesalers, Durable Goods - 0.5%

     
 

4,084

   

Hyster-Yale Materials Handling, Inc.

   

119,089

   

Miscellaneous Manufacturing - 0.5%

     
 

53,568

    Hexagon Purus Holding AS
(Norway) (a)
   

103,871

   

Oil and Gas Extraction - 18.2%

     
 

30,166

   

BP Plc (United Kingdom) ADR (a)

   

1,003,925

   
 

102,805

    CIMC Enric Holdings Limited
(Hong Kong)
   

100,187

   
 

293,081

   

ENEOS Holdings, Inc. (Japan)

   

965,796

   
 

43,624

   

Idemitsu Kosan Co., Ltd (Japan)

   

953,867

   
 

17,853

   

Shell Plc (United Kingdom) ADR (a)

   

993,162

   
     

4,016,937

   

Primary Metal Manufacturing - 0.5%

     
 

30,352

    Kaori Heat Treatment Co., Ltd.
(Taiwan)
   

110,208

   

Transportation Equipment Manufacturing - 6.9%

     
 

270,177

    Ballard Power Systems, Inc.
(Canada) ADR (a)(b)
   

1,531,904

   

Shares

     

Fair Value

 

Utilities - 9.4%

     
 

1,008,214

    AFC Energy Plc
(United Kingdom) (a)
 

$

246,090

   
 

144,274

    Ceres Power Holdings Plc
(United Kingdom) (a)(b)
   

544,505

   
 

311,189

   

FuelCell Energy, Inc. (a)

   

970,910

   
 

4,538

   

Korea Gas Corp. (South Korea)

   

110,865

   
 

15,602

   

S-Fuelcell Co., Ltd (South Korea)

   

219,608

   

   

2,091,978

   
        TOTAL COMMON STOCKS
(Cost $35,743,613)
 

$

21,924,836

   

SHORT TERM INVESTMENTS - 17.7%

     

Money Market Funds - 17.7%

     
 

3,905,853

    Dreyfus Government Cash
Management Institutional
Shares, 2.91% (c)(d)
 

$

3,905,853

   
        TOTAL SHORT TERM
INVESTMENTS
(Cost $3,905,853)
 

$

3,905,853

   
        TOTAL INVESTMENTS
(Cost $39,649,466) - 116.7%
 

$

25,830,689

   
        Liabilities in Excess of
Other Assets - (16.7%)
   

(3,692,014

)

 
       

TOTAL NET ASSETS - 100.0%

 

$

22,138,675

   

Percentages are stated as a percent of net assets.

The geographic location of all investments is United States unless otherwise indicated.

(a)  Non-income producing security.

(b)  A portion of this security represents a security on loan.

(c)  Represents annualized seven-day yield at October 31, 2022.

(d)  All or a portion of this security represents an investment of securities lending collateral.

ADR - American Depository Receipt

The accompanying notes are an integral part of these financial statements.

DIREXION ANNUAL REPORT
23


Direxion Moonshot Innovators ETF

Schedule of Investments

October 31, 2022

Shares

     

Fair Value

 

COMMON STOCKS - 99.5%

     

Administrative and Support Services - 5.3%

     
 

26,146

   

Roblox Corp. (a)

 

$

1,169,772

   
 

37,014

   

SentinelOne, Inc. (a)

   

845,400

   
     

2,015,172

   

Ambulatory Health Care Services - 2.2%

     
 

325,057

   

Invitae Corp. (a)(b)

   

838,647

   

Chemical Manufacturing - 8.0%

     
 

58,094

    Arcturus Therapeutics
Holdings, Inc. (a)
   

1,028,264

   
 

100,579

   

BridgeBio Pharma, Inc. (a)

   

1,049,039

   
 

17,590

   

Intellia Therapeutics, Inc. (a)

   

928,400

   
     

3,005,703

   
Computer and Electronic Product
Manufacturing - 12.1%
     
 

13,235

   

Ambarella Inc. ADR (a)

   

724,352

   
 

145,420

   

Indie Semiconductor, Inc. (a)

   

1,137,184

   
 

226,912

   

MicroVision, Inc. (a)(b)

   

830,498

   
 

289,944

   

Nano Dimension Ltd. ADR (Israel) (a)

   

719,061

   
 

109,474

   

Ondas Holdings, Inc. (a)(b)

   

437,896

   
 

140,421

   

Vuzix Corp. (a)(b)

   

702,105

   
     

4,551,096

   

Construction of Buildings - 0.3%

     
 

114,105

   

Xos, Inc. (a)

   

128,939

   

Electronics and Appliance Stores - 1.5%

     
 

43,982

   

UiPath, Inc. (a)

   

556,372

   

Food Services and Drinking Places - 3.2%

     
 

31,759

   

Yelp, Inc. (a)

   

1,219,863

   

Management of Companies and Enterprises - 1.3%

     
 

66,671

   

CureVac N.V. ADR (Netherlands) (a)

   

485,365

   

Merchant Wholesalers, Nondurable Goods - 1.7%

     
 

133,629

   

Atara Biotherapeutics, Inc. (a)

   

622,711

   

Miscellaneous Manufacturing - 2.8%

     
 

481,750

   

Inovio Pharmaceuticals, Inc. (a)

   

1,040,580

   

Motion Picture and Sound Recording Industries - 1.8%

     
 

62,130

   

ADEIA, Inc.

   

694,613

   

Nonstore Retailers - 1.8%

     
 

136,146

    Jumia Technologies AG ADR
(Germany) (a)
   

675,284

   

Oil and Gas Extraction - 2.3%

     
 

816,876

   

Meta Materials, Inc. (a)

   

865,888

   

Printing and Related Support Activities - 2.2%

     
 

102,331

   

Fisker, Inc. (a)(b)

   

833,998

   

Professional, Scientific, and Technical Services - 13.7%

     
 

46,070

   

Asana, Inc. (a)

   

949,042

   
 

56,325

   

Avidity Biosciences, Inc. (a)

   

804,321

   
 

79,726

   

Local Bounti Corp. (a)(b)

   

235,989

   
 

9,661

   

Okta, Inc. (a)

   

542,175

   
 

97,353

    Sarcos Technology and
Robotics Corp. (a)
   

196,653

   
 

42,524

   

Squarespace, Inc. (a)

   

944,458

   
 

109,360

   

Tusimple Holdings, Inc. (a)

   

375,105

   
 

21,177

   

Unity Software, Inc. (a)

   

624,721

   
 

135,362

   

Vimeo, Inc. (a)

   

514,376

   
     

5,186,840

   

Shares

     

Fair Value

 

Publishing Industries (except Internet) - 3.3%

     
 

48,851

   

C3.ai, Inc. (a)

 

$

640,437

   
 

71,657

   

Fastly, Inc. (a)

   

608,368

   
     

1,248,805

   

Securities, Commodity Contracts, and Other Financial Investments and Related Activities - 36.0%

     
 

240,651

   

Aeva Technologies, Inc. (a)

   

481,302

   
 

345,482

   

AEye, Inc. (a)

   

300,742

   
 

428,953

   

Aurora Innovation, Inc. (a)

   

883,643

   
 

243,762

   

Benson Hill, Inc. (a)

   

826,353

   
 

293,566

   

Butterfly Network, Inc. (a)(b)

   

1,438,473

   
 

406,671

   

Desktop Metal, Inc. (a)(b)

   

1,028,878

   
 

336,707

    Ginkgo Bioworks Holdings, Inc.
Class A (a)(b)
   

919,210

   
 

258,079

   

Hyliion Holdings Corp. (a)

   

735,525

   
 

282,105

   

Hyzon Motors, Inc. (a)

   

538,821

   
 

236,034

    Inoviz Technologies Ltd. ADR
(Israel) (a)
   

1,182,530

   
 

757,591

   

Latch, Inc. (a)

   

1,015,172

   
 

536,808

   

Ouster, Inc. (a)

   

671,010

   
 

155,133

   

Pear Therapeutics, Inc. (a)

   

426,616

   
 

192,899

   

Planet Labs PBC (a)

   

1,012,720

   
 

131,492

   

Roivant Sciences Ltd. ADR (a)(b)

   

675,869

   
 

831,337

   

Velodyne Lidar, Inc. (a)

   

820,945

   
 

141,477

   

Virgin Galactic Holdings, Inc. (a)(b)

   

653,624

   
     

13,611,433

   
        TOTAL COMMON STOCKS
(Cost $66,014,382)
 

$

37,581,309

   

SHORT TERM INVESTMENTS - 16.7%

     

Money Market Funds - 16.7%

     
 

6,325,075

    Dreyfus Government Cash
Management Institutional
Shares, 2.91% (c)(d)
 

$

6,325,075

   
        TOTAL SHORT TERM
INVESTMENTS
(Cost $6,325,075)
 

$

6,325,075

   
        TOTAL INVESTMENTS
(Cost $72,339,457) - 116.2%
 

$

43,906,384

   
        Liabilities in Excess of
Other Assets - (16.2)%
   

(6,134,585

)

 
       

TOTAL NET ASSETS - 100.0%

 

$

37,771,799

   

Percentages are stated as a percent of net assets.

The geographic location of all investments is United States unless otherwise indicated.

(a)  Non-income producing security.

(b)  A portion of this security represents a security on loan.

(c)  Represents annualized seven-day yield at October 31, 2022.

(d)  All or a portion of this security represents an investment of securities lending collateral.

ADR - American Depository Receipt

The accompanying notes are an integral part of these financial statements.

DIREXION ANNUAL REPORT
24


Direxion mRNA ETF

Schedule of Investments

October 31, 2022

Shares

     

Fair Value

 

COMMON STOCKS - 99.8%

     

Chemical Manufacturing - 58.5%

     
 

746

   

Alnylam Pharmaceuticals, Inc. (a)

 

$

154,616

   
 

81,701

    Arbutus Biopharma Corp. ADR
(Canada) (a)
   

191,180

   
 

9,187

    Arcturus Therapeutics
Holdings, Inc. (a)
   

162,610

   
 

1,286

   

BeiGene Ltd. ADR (a)

   

217,192

   
 

2,786

   

Intellia Therapeutics, Inc. (a)

   

147,045

   
 

3,398

   

Ionis Pharmaceuticals, Inc. (a)

   

150,192

   
 

7,905

    Maravai LifeSciences
Holdings, Inc. (a)
   

131,223

   
 

7,393

   

PepGen, Inc. (a)

   

90,786

   
 

32,241

   

Sangamo Therapeutics, Inc. (a)

   

141,538

   
 

2,180

   

Sarepta Therapeutics, Inc. (a)

   

248,564

   
 

12,474

   

Stoke Therapeutics, Inc. (a)

   

185,239

   
 

822

   

Vertex Pharmaceuticals, Inc. (a)

   

256,464

   
     

2,076,649

   

Management of Companies and Enterprises - 4.2%

     
 

20,292

   

CureVac N.V. ADR (Netherlands) (a)

   

147,726

   

Merchant Wholesalers, Durable Goods - 3.9%

     
 

12,268

   

Dyne Therapeutics, Inc. (a)

   

139,855

   
   

Professional, Scientific, and Technical Services - 33.2%

 
 

4,568

   

Arrowhead Pharmaceuticals, Inc. (a)

   

159,012

   
 

9,527

   

Avidity Biosciences, Inc. (a)

   

136,046

   
 

1,802

   

BioNTech SE ADR (Germany)

   

248,027

   
 

50,816

   

Gritstone bio, Inc. (a)

   

163,627

   
 

2,034

   

Moderna, Inc. (a)

   

305,771

   
 

106,882

   

Sorrento Therapeutics Inc. (a)

   

167,805

   
     

1,180,288

   
        TOTAL COMMON STOCKS
(Cost $4,051,204)
 

$

3,544,518

   

SHORT TERM INVESTMENTS - 0.0% (†)

     

Money Market Funds - 0.0% (†)

     
 

91

    Dreyfus Government Cash
Management Institutional
Shares, 2.91% (b)
 

$

91

   
        TOTAL SHORT TERM
INVESTMENTS
(Cost $91)
 

$

91

   
        TOTAL INVESTMENTS
(Cost $4,051,295) - 99.8%
 

$

3,544,609

   
        Other Assets in Excess of
Liabilities - 0.2%
   

5,675

   
       

TOTAL NET ASSETS - 100.0%

 

$

3,550,284

   

Percentages are stated as a percent of net assets.

The geographic location of all investments is United States unless otherwise indicated.

(†)  Less than 0.05%.

(a)  Non-income producing security.

(b)  Represents annualized seven-day yield at October 31, 2022.

ADR - American Depository Receipt

The accompanying notes are an integral part of these financial statements.

DIREXION ANNUAL REPORT
25


Direxion Nanotechnology ETF

Schedule of Investments

October 31, 2022

Shares

     

Fair Value

 

COMMON STOCKS - 99.9%

     

Chemical Manufacturing - 31.8%

     
 

1,280

   

Aadi Bioscience, Inc. (a)

 

$

16,531

   
 

1,909

   

Alkermes PLC ADR (Ireland) (a)

   

43,334

   
 

219

   

Alnylam Pharmaceuticals, Inc. (a)

   

45,390

   
 

5,630

    Arcturus Therapeutics
Holdings, Inc. (a)
   

99,651

   
 

3,407

   

Beam Therapeutics, Inc. (a)

   

150,113

   
 

664

   

Cabot Corp.

   

48,791

   
 

3,897

   

Generation Bio Co. (a)

   

19,953

   
 

880

   

Intellia Therapeutics, Inc. (a)

   

46,446

   
 

304

    Jazz Pharmaceuticals PLC ADR
(Ireland) (a)
   

43,712

   
     

513,921

   
Computer and Electronic Product
Manufacturing - 39.2%
     
 

378

   

AMETEK, Inc.

   

49,012

   
 

58,210

   

Bionano Genomics, Inc. (a)(b)

   

136,211

   
 

2,972

   

Bruker Corp.

   

183,788

   
 

167

   

Danaher Corp.

   

42,029

   
 

521

   

Lumentum Holdings, Inc. (a)

   

38,788

   
 

25,724

   

Nano Dimension Ltd. ADR (Israel) (a)

   

63,796

   
 

334

   

NVE Corp.

   

20,711

   
 

2,998

   

Seer, Inc. (a)

   

23,474

   
 

83

   

Thermo Fisher Scientific, Inc.

   

42,660

   
 

6,269

   

Vuzix Corp. (a)(b)

   

31,345

   
     

631,814

   

Machinery Manufacturing - 5.7%

     
 

226

   

IDEX Corp.

   

50,242

   
 

104

   

Lam Research Corp.

   

42,097

   
     

92,339

   

Merchant Wholesalers, Durable Goods - 2.6%

     
 

133

   

KLA-Tencor Corp.

   

42,088

   

Merchant Wholesalers, Nondurable Goods - 1.7%

     
 

5,100

   

PDS Biotechnology Corp. (a)

   

26,724

   

Miscellaneous Manufacturing - 1.5%

     
 

1,761

   

AngioDynamics, Inc. (a)

   

24,813

   

Oil and Gas Extraction - 5.0%

     
 

76,319

   

Meta Materials, Inc. (a)

   

80,898

   

Professional, Scientific, and Technical Services - 9.1%

     
 

322

   

BioNTech SE ADR (Germany)

   

44,320

   
 

10,836

   

Liquidia Technologies, Inc. (a)

   

52,988

   
 

334

   

Moderna, Inc. (a)

   

50,210

   
     

147,518

   

Securities, Commodity Contracts, and Other Financial Investments and Related Activities - 3.3%

     
 

10,243

   

Roivant Sciences Ltd. ADR (a)

   

52,649

   
        TOTAL COMMON STOCKS
(Cost $2,012,813)
 

$

1,612,764

   

Shares

     

Fair Value

 

SHORT TERM INVESTMENTS - 0.1%

 

Money Market Funds - 0.1%

 
  144,050     Dreyfus Government Cash
Management Institutional
Shares, 2.91% (c)(d)
 

$

144,050

   
    TOTAL SHORT TERM
INVESTMENTS
(Cost $144,050)
 

$

144,050

   
    TOTAL INVESTMENTS
(Cost $2,156,863) - 108.9%
 

$

1,756,814

   
    Liabilities in Excess of
Other Assets - (8.9)%
   

(142,921

)

 
   

TOTAL NET ASSETS - 100.0%

 

$

1,613,893

   

Percentages are stated as a percent of net assets.

The geographic location of all investments is United States unless otherwise indicated.

(a)  Non-income producing security.

(b)  A portion of this security represents a security on loan.

(c)  Represents annualized seven-day yield at October 31, 2022.

(d)  All or a portion of this security represents an investment of securities lending collateral.

ADR - American Depository Receipt

The accompanying notes are an integral part of these financial statements.

DIREXION ANNUAL REPORT
26


Direxion NASDAQ-100® Equal Weighted Index Shares

Schedule of Investments

October 31, 2022

Shares

     

Fair Value

 

COMMON STOCKS - 99.9%

     

Accommodation - 1.0%

     
 

45,305

    Marriott International, Inc.
Class A
 

$

7,253,784

   

Administrative and Support Services - 2.9%

     
 

28,895

   

Atlassian Corp. (a)

   

5,857,884

   
 

30,040

   

Automatic Data Processing, Inc.

   

7,260,668

   
 

3,740

   

Booking Holdings, Inc. (a)

   

6,991,855

   
     

20,110,407

   

Apparel Manufacturing - 1.0%

     
 

21,061

   

Lululemon Athletica, Inc. (a)

   

6,929,911

   

Beverage and Tobacco Product Manufacturing - 3.2%

     
 

188,825

   

Keurig Dr Pepper, Inc.

   

7,333,963

   
 

80,452

   

Monster Beverage Corp. (a)

   

7,539,962

   
 

42,035

   

PepsiCo, Inc.

   

7,632,715

   
     

22,506,640

   

Broadcasting and Content Providers - 2.9%

     
 

18,589

   

Charter Communications, Inc. (a)

   

6,833,688

   
 

203,313

   

Comcast Corp. Class A

   

6,453,155

   
 

1,175,650

   

Sirius XM Holdings, Inc. (b)

   

7,100,926

   
     

20,387,769

   

Chemical Manufacturing - 7.8%

     
 

30,365

   

Amgen, Inc.

   

8,209,178

   
 

120,907

    AstraZeneca PLC ADR
(United Kingdom)
   

7,110,540

   
 

33,701

   

Biogen, Inc. (a)

   

9,552,211

   
 

106,991

   

Gilead Sciences, Inc.

   

8,394,514

   
 

9,881

   

Regeneron Pharmaceuticals, Inc. (a)

   

7,398,399

   
 

49,417

   

Seagen, Inc. (a)

   

6,283,866

   
 

24,227

   

Vertex Pharmaceuticals, Inc. (a)

   

7,558,824

   
     

54,507,532

   

Clothing, Clothing Accessories, Shoe, and Jewelry Retailers - 1.0%

     
 

77,777

   

Ross Stores, Inc.

   

7,442,481

   

Computer and Electronic Product Manufacturing - 17.6%

     
 

91,734

   

Advanced Micro Devices, Inc. (a)

   

5,509,544

   
 

34,137

   

Alphabet, Inc. Class A (a)

   

3,226,288

   
 

33,864

   

Alphabet, Inc. Class C (a)

   

3,205,566

   
 

47,007

   

Analog Devices, Inc.

   

6,704,138

   
 

46,574

   

Apple, Inc.

   

7,141,657

   
 

13,968

   

Broadcom, Inc.

   

6,566,636

   
 

162,093

   

Cisco Systems, Inc.

   

7,363,885

   
 

139,203

   

Fortinet, Inc. (a)

   

7,956,843

   
 

20,489

   

IDEXX Laboratories, Inc. (a)

   

7,369,483

   
 

35,123

   

Illumina, Inc. (a)

   

8,036,845

   
 

240,035

   

Intel Corp.

   

6,824,195

   
 

151,426

   

Marvell Technology, Inc.

   

6,008,584

   
 

106,828

   

Microchip Technology, Inc.

   

6,595,561

   
 

132,803

   

Micron Technology, Inc.

   

7,184,642

   
 

53,179

   

NVIDIA Corp. (a)

   

7,177,570

   
 

43,883

    NXP Semiconductors NV ADR
(Netherlands)
   

6,410,429

   

Shares

     

Fair Value

 
Computer and Electronic Product
Manufacturing (continued)
     
 

56,172

   

Qualcomm, Inc.

 

$

6,609,198

   
 

70,270

   

Skyworks Solutions, Inc.

   

6,043,923

   
 

42,470

   

Texas Instruments, Inc.

   

6,821,956

   
     

122,756,943

   

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services - 1.0%

     
 

67,741

   

Fiserv, Inc. (a)

   

6,959,710

   

Food Manufacturing - 2.1%

     
 

116,395

   

Mondelez International, Inc.

   

7,155,965

   
 

202,207

   

The Kraft Heinz Co.

   

7,778,903

   
     

14,934,868

   

Food Services and Drinking Places - 2.0%

     
 

17,358

   

Cintas Corp.

   

7,421,413

   
 

76,866

   

Starbucks Corp.

   

6,655,827

   
     

14,077,240

   

General Merchandise Retailers - 6.4%

     
 

56,817

   

Amazon.com, Inc. (a)

   

5,820,334

   
 

13,922

   

Costco Wholesale Corp.

   

6,981,883

   
 

49,455

   

Dollar Tree, Inc. (a)

   

7,838,618

   
 

167,110

   

eBay, Inc.

   

6,657,662

   
 

126,759

   

JD.com, Inc. ADR (China)

   

4,726,843

   
 

7,636

   

MercadoLibre, Inc. (a)

   

6,884,770

   
 

106,886

   

Pinduoduo, Inc. ADR (China) (a)

   

5,860,559

   
     

44,770,669

   

Health and Personal Care Stores - 1.1%

     
 

204,804

   

Walgreens Boots Alliance, Inc.

   

7,475,346

   

Machinery Manufacturing - 3.0%

     
 

78,976

   

Applied Materials, Inc.

   

6,972,791

   
 

15,021

    ASML Holding NV ADR
(Netherlands)
   

7,096,221

   
 

17,151

   

Lam Research Corp.

   

6,942,382

   
     

21,011,394

   

Merchant Wholesalers, Durable Goods - 3.0%

     
 

63,747

   

Copart, Inc. (a)

   

7,332,180

   
 

148,190

   

Fastenal Co.

   

7,162,023

   
 

20,918

   

KLA-Tencor Corp.

   

6,619,501

   
     

21,113,704

   

Miscellaneous Manufacturing - 3.3%

     
 

28,185

   

Align Technology, Inc. (a)

   

5,476,346

   
 

77,907

   

DexCom, Inc. (a)

   

9,409,607

   
 

34,026

   

Intuitive Surgical, Inc. (a)

   

8,386,388

   
     

23,272,341

   

Motion Picture and Sound Recording Industries - 1.2%

     
 

29,229

   

Netflix, Inc. (a)

   

8,531,361

   

Motor Vehicle and Parts Dealers - 1.2%

     
 

10,120

   

O'Reilly Automotive, Inc. (a)

   

8,472,160

   

Performing Arts, Spectator Sports, and Related Industries - 2.0%

     
 

92,326

   

Activision Blizzard, Inc.

   

6,721,333

   
 

57,659

   

Electronic Arts, Inc.

   

7,262,727

   
     

13,984,060

   

The accompanying notes are an integral part of these financial statements.

DIREXION ANNUAL REPORT
27


Direxion NASDAQ-100® Equal Weighted Index Shares

Schedule of Investments, continued

October 31, 2022

Shares

     

Fair Value

 

Professional, Scientific, and Technical Services - 11.2%

     
 

56,743

   

Baidu, Inc. ADR (China) (a)

 

$

4,344,812

   
 

112,840

    Cognizant Technology
Solutions Corp. Class A
   

7,024,290

   
 

126,759

   

Match Group, Inc. (a)

   

5,475,989

   
 

47,977

   

Meta Platforms, Inc. (a)

   

4,469,537

   
 

50,956

   

Moderna, Inc. (a)

   

7,660,215

   
 

118,940

   

Okta, Inc. (a)

   

6,674,913

   
 

40,316

   

Palto Alto Networks, Inc. (a)

   

6,917,822

   
 

58,425

   

Paychex, Inc.

   

6,912,262

   
 

40,099

   

VeriSign, Inc. (a)

   

8,038,246

   
 

38,056

   

Verisk Analytics, Inc. Class A

   

6,957,778

   
 

46,088

   

Workday, Inc. (a)

   

7,181,432

   
 

41,410

   

Zscaler, Inc. (a)

   

6,381,281

   
     

78,038,577

   

Publishing Industries - 10.5%

     
 

23,434

   

Adobe Systems, Inc. (a)

   

7,463,729

   
 

29,154

   

ANSYS, Inc. (a)

   

6,447,699

   
 

35,999

   

Autodesk, Inc. (a)

   

7,714,586

   
 

42,726

   

Cadence Design Systems, Inc. (a)

   

6,468,289

   
 

41,043

   

CrowdStrike Holdings, Inc. (a)

   

6,616,132

   
 

76,917

   

Datadog, Inc. (a)

   

6,192,588

   
 

124,048

   

DocuSign, Inc. (a)

   

5,991,518

   
 

16,593

   

Intuit, Inc.

   

7,093,507

   
 

28,678

   

Microsoft Corp.

   

6,657,024

   
 

77,306

   

Splunk, Inc. (a)

   

6,424,902

   
 

22,337

   

Synopsys, Inc. (a)

   

6,534,689

   
     

73,604,663

   

Rail Transportation - 1.0%

     
 

238,000

   

CSX Corp.

   

6,916,280

   

Rental and Leasing Services - 0.9%

     
 

59,104

   

Airbnb, Inc. (a)

   

6,318,809

   

Securities, Commodity Contracts, and Other Financial Investments and Related Activities - 0.9%

     
 

433,785

   

Lucid Group, Inc. (a)(b)

   

6,198,788

   

Specialty Trade Contractors - 0.7%

     
 

84,858

   

NetEase.com, Inc. ADR (China) (a)

   

4,719,802

   

Telecommunications - 3.0%

     
 

74,666

   

PayPal Holdings, Inc. (a)

   

6,240,584

   
 

50,151

   

T-Mobile US, Inc. (a)

   

7,600,886

   
 

89,205

    Zoom Video Communications,
Inc. (a)
   

7,443,265

   
     

21,284,735

   

Transportation Equipment Manufacturing - 3.1%

     
 

39,575

   

Honeywell International, Inc.

   

8,074,091

   
 

82,436

   

Paccar, Inc.

   

7,982,278

   
 

23,137

   

Tesla Motors, Inc. (a)

   

5,264,593

   
     

21,320,962

   

Truck Transportation - 1.1%

     
 

27,629

   

Old Dominion Freight Line, Inc.

   

7,586,923

   

Shares

     

Fair Value

 

Utilities - 3.8%

     
 

69,935

   

American Electric Power Co., Inc.

 

$

6,148,685

   
 

82,022

   

Constellation Energy Corp.

   

7,754,360

   
 

162,439

   

Exelon Corp.

   

6,268,521

   
 

94,974

   

Xcel Energy, Inc.

   

6,183,757

   
     

26,355,323

   
        TOTAL COMMON STOCKS
(Cost $806,517,465)
 

$

698,843,182

   

SHORT TERM INVESTMENTS - 1.9%

     

Money Market Funds - 1.9%

     
 

13,201,004

    Dreyfus Government Cash
Management Institutional
Shares, 2.91% (c)(d)
 

$

13,201,004

   
        TOTAL SHORT TERM
INVESTMENTS
(Cost $13,201,004)
 

$

13,201,004

   
        TOTAL INVESTMENTS
(Cost $819,718,469) - 101.8%
 

$

712,044,186

   
        Liabilities in Excess of
Other Assets - (1.8)%
   

(12,368,168

)

 
       

TOTAL NET ASSETS - 100.0%

 

$

699,676,018

   

Percentages are stated as a percent of net assets.

The geographic location of all investments is United States unless otherwise indicated.

(a)  Non-income producing security.

(b)  A portion of this security represents a security on loan.

(c)  Represents annualized seven-day yield at October 31, 2022.

(d)  All or a portion of this security represents an investment of securities lending collateral.

ADR - American Depository Receipt

The accompanying notes are an integral part of these financial statements.

DIREXION ANNUAL REPORT
28


Direxion Work From Home ETF

Schedule of Investments

October 31, 2022

Shares

     

Fair Value

 

COMMON STOCKS - 99.7%

     

Administrative and Support Services - 6.7%

     
 

11,654

   

Alibaba Group Holding Ltd. ADR (a)

 

$

740,961

   
 

4,485

   

Atlassian Corp. (a)

   

909,244

   
 

41,085

   

SentinelOne, Inc. (a)

   

938,382

   
     

2,588,587

   

Computer and Electronic Product Manufacturing - 21.0%

     
 

9,647

   

Alphabet, Inc. Class A (a)

   

911,738

   
 

520,142

   

Avaya Holdings Corp. (a)(b)

   

821,824

   
 

2,090

   

Broadcom, Inc.

   

982,551

   
 

23,454

   

Cisco Systems, Inc.

   

1,065,515

   
 

20,929

   

Fortinet, Inc. (a)

   

1,196,302

   
 

8,268

    International Business
Machines Corp.
   

1,143,382

   
 

22,581

   

Marvell Technology, Inc.

   

896,014

   
 

14,935

   

NetApp, Inc.

   

1,034,547

   
     

8,051,873

   

Data Processing, Hosting and Related Services - 5.0%

     
 

24,647

   

RingCentral, Inc. (a)

   

875,461

   
 

9,132

   

VMware, Inc.

   

1,027,624

   
     

1,903,085

   

Electronics and Appliance Stores - 2.9%

     
 

31,519

   

Smartsheet, Inc. (a)

   

1,100,644

   

Management of Companies and Enterprises - 3.0%

     
 

60,718

    America Movil SAB de CV
Series L ADR (Mexico)
   

1,142,106

   

Nonstore Retailers - 2.2%

     
 

8,155

   

Amazon.com, Inc. (a)

   

835,398

   

Professional, Scientific, and Technical Services - 23.3%

     
 

6,583

   

Meta Platforms, Inc. (a)

   

613,272

   
 

46,991

   

Nutanix, Inc. (a)

   

1,287,553

   
 

17,256

   

Okta, Inc. (a)

   

968,407

   
 

5,866

   

Palto Alto Networks, Inc. (a)

   

1,006,547

   
 

221,825

   

Rackspace Technology, Inc. (a)(b)

   

1,142,399

   
 

2,377

   

ServiceNow, Inc. (a)

   

1,000,099

   
 

91,896

   

Sprinklr, Inc. (a)

   

850,038

   
 

6,370

   

Workday, Inc. (a)

   

992,573

   
 

7,148

   

Zscaler, Inc. (a)

   

1,101,507

   
     

8,962,395

   

Publishing Industries (except Internet) - 30.4%

     
 

2,781

   

Adobe Systems, Inc. (a)

   

885,748

   
 

263,972

   

Agora, Inc. ADR (a)

   

736,482

   
 

40,316

   

Box, Inc. (a)

   

1,171,180

   
 

6,140

   

CrowdStrike Holdings, Inc. (a)

   

989,768

   
 

7,410

    CyberArk Software Ltd. ADR
(Israel) (a)
   

1,162,703

   
 

19,149

   

DocuSign, Inc. (a)

   

924,897

   
 

1,291,133

   

Exela Technologies, Inc. (a)

   

306,644

   
 

4,091

   

Microsoft Corp.

   

949,644

   
 

14,175

   

Oracle Corp.

   

1,106,642

   
 

22,596

   

Progress Software Corp.

   

1,153,074

   
 

6,889

   

Salesforce.com, Inc. (a)

   

1,120,082

   
 

15,551

   

Twilio, Inc. (a)

   

1,156,528

   
     

11,663,392

   

Shares

     

Fair Value

 

Telecommunications - 5.2%

     
 

219,977

   

8x8, Inc. (a)

 

$

930,503

   
 

13,032

    Zoom Video Communications,
Inc. (a)
   

1,087,390

   
     

2,017,893

   
        TOTAL COMMON STOCKS
(Cost $58,862,058)
 

$

38,265,373

   

SHORT TERM INVESTMENTS - 1.7%

     

Money Market Funds - 1.7%

     
 

654,039

    Dreyfus Government Cash
Management Institutional
Shares, 2.91% (c)(d)
 

$

654,039

   
        TOTAL SHORT TERM
INVESTMENTS
(Cost $654,039)
 

$

654,039

   
        TOTAL INVESTMENTS
(Cost $59,516,097) - 101.4%<